Huntington’s disease is largely considered a neurodegenerative disease, with very little impact on development due to late onset of symptoms and the ability of mHtt expression to rescue embryonic lethality in HTT-null mice (Zeitlin et al., 1995; Leavitt et al., 2001). This evidence concerns the gene HTT and Huntington disease.